Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Vivek Gupta, PhD

Associate Professor
St. John's University
Queens, New York

Dr. Vivek Gupta is Associate Professor of Pharmaceutical Sciences at St. John’s University and the Scientific Founder of PulmoSIM Therapeutics, a biotech company focused on the development of inhaled therapies for rare respiratory diseases. His research centers on non-invasive drug delivery systems—including inhalable nanomedicine, oral delivery of biologics, and localized delivery approaches for brain and lung diseases, aimed at improving therapeutic efficacy and patient outcomes. Dr. Gupta brings deep translational expertise developed through a prolific academic career and through industry-facing innovation. He has authored over 120 peer-reviewed publications and is an inventor on over 20 U.S. and international patents, several of which have been licensed for clinical development. He has led pioneering work in scalable nanomedicine manufacturing and in the formulation of repurposed drugs for oncology, fibrosis, and pulmonary hypertension. Dr. Gupta is an invited speaker at international scientific forums, serves on multiple editorial boards, and is on multiple NIH review panels. His current work continues to bridge pharmaceutical innovation and real-world application, advancing the next generation of therapeutics for hard-to-treat diseases.

Disclosure information not submitted.

Presentation(s):